The major cell-surface receptor for HA is CD44; its expression is increased in the sites of tumor invasion and one of its isoforms, CD-44v3, has been closely linked to progression and to chemoresistance of UADT SCC [191]. The gene discussed is CD44; the disease is neoplasm.